tickrz reports
tickrz rank
C
Baxter International Inc (BAX)
Healthcare | Health Services
63.63  1.31%
FACTOR RANKINGSFACTOR SCREENER 
tickrz RankC / 278Warren Buffett RankB / 159
Pure Value RankC / 352Dividend RankA / 14
Moat RankB / 168Financial Strength RankA / 25
Growth RankC / 251Momentum RankA / 95
BAX vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
BAXSECTORS&P 500
P/E RATIO38.3131.619.61
EV/EBITDA RATIO18.3716.911.89
P/S RATIO3.393.62.06
P/B RATIO3.85.53.15
QUALITY
RETURN ON EQUITY10.3%15.64%13.85%
RETURN ON CAPITAL11.26%50.61%10.02%
NET MARGIN48.86%8.18%9.77%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.92%
PAYOUT RATIO31.1%
3 YR DIVIDEND GROWTH-35.93%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
8 OUT OF 9
DEBT-TO-EQUITY38%
INTEREST COVERAGE9.91x
CURRENT RATIO3.01
GROWTH
5 YR EPS GROWTH18.26%
5 YR SPS GROWTH-6.06%
5 YR BPS GROWTH5.53%
About tickrz
Key Concepts
Great Investors
Baxter International Inc's strong Dividend Rank may warrant a closer look for investors seeking dividend paying stocks
tickrz rank C / 278
Baxter International Inc receives a C ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
value
pure value ranking C / 352Warren Buffett ranking B / 159
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Baxter International Inc's valuation score is comprised of a P/E ratio of 38.3x, a P/B ratio of 3.8x, a P/S ratio of 3.4x, and an EV/EBITDA ratio of 18.4x. Baxter International Inc ranks 352 out of the S&P 500 constituents on valuation--a relatively weak score.Baxter International Inc ranks 159 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a average score, meaning it ranks in the middle of the pack on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Baxter International Inc is probably not for you.

quality
moat B / 168financial strength A / 25
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.Baxter International Inc has a Piotroski F Score of 8 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 9.91x, a debt/equity ratio of 38% and a Moat Rank of 168 translate to a strong Financial Strength score.


momentum A / 95
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 35.39% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 95. Baxter International Inc's strong 12 month stock performance will appeal to momentum investors.

yield A / 14
value + yield
Shares currently yield 0.92%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Baxter International Inc ranks 14 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate Baxter International Inc.

growth C / 251
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the bottom third of S&P500 companies. Its 18.3% 5 year annualized EPS growth, -6.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 5.5% speak to its relatively poor ranking.

Baxter International Inc (BAX)
Healthcare | Health Services
63.63  1.31%


tickrz rank
C
VALUATION RATIOS
P/E Ratio38.31x
P/B Ratio3.8x
P/S Ratio3.39x
EV/EBITDA Ratio18.37x
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.92%
PAYOUT RATIO31.1%
3 YR DIVIDEND GROWTH-35.93%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
8 OUT OF 9
DEBT-TO-EQUITY38%
INTEREST COVERAGE9.91x
CURRENT RATIO3.01
MOAT
ROE10.3%
ROIC11.26%
Net Margin48.86%
GROWTH
5 YR EPS GROWTH18.26%
5 YR SPS GROWTH-6.06%
5 YR BPS GROWTH5.53%

TICKRZ RANK
Baxter International Inc receives a C ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Baxter International Inc's valuation score is comprised of a P/E ratio of 38.3x, a P/B ratio of 3.8x, a P/S ratio of 3.4x, and an EV/EBITDA ratio of 18.4x. Baxter International Inc ranks 352 out of the S&P 500 constituents on valuation--a relatively weak score.

WARREN BUFFETT RANKING
Baxter International Inc ranks 159 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a average score, meaning it ranks in the middle of the pack on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Baxter International Inc is probably not for you.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.

FINANCIAL STRENGTH
Baxter International Inc has a Piotroski F Score of 8 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 9.91x, a debt/equity ratio of 38% and a Moat Rank of 168 translate to a strong Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 35.39% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 95. Baxter International Inc's strong 12 month stock performance will appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.92%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Baxter International Inc ranks 14 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate Baxter International Inc.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the bottom third of S&P500 companies. Its 18.3% 5 year annualized EPS growth, -6.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 5.5% speak to its relatively poor ranking.